Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Wagenmann

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|December 29, 2023
Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal PolypsClaire Hopkins, Joaquim Mullol, Asif H Khan, et al.
Journal of Asthma and Allergy|April 5, 2023
Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 TrialJorge F Maspero, Asif H Khan, Carl Philpott, et al.
Allergologie Select|June 3, 2021
Precision medicine reaching out to the patients in allergology - a German-Japanese workshop reportOliver Pfaar, Katharina Blumchen, Eistine Boateng, et al.
The Journal of Allergy and Clinical Immunology|February 24, 2023
Nasal allergen challenge (NAC): Practical aspects and applications from an EU/US perspective-a Work Group Report of the AAAAI Rhinitis, Rhinosinusitis and Ocular Allergy CommitteeSeong H Cho, Anil Nanda, Anjeni Keswani, et al.
Eclinicalmedicine|January 27, 2025
Roads to remission: evolving treatment concepts in type 2 inflammatory diseasesMarek Lommatzsch, Katharina Blumchen, Lisa A Beck, et al.
The Lancet. Respiratory Medicine|October 1, 2025
Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trialEugenio De Corso, G Walter Canonica, Enrico Heffler, et al.
The Journal of Allergy and Clinical Immunology|November 1, 2024
Real-world effectiveness of dupilumab in a European cohort of chronic rhinosinusitis with nasal polyps (CHRINOSOR)Sven F Seys, Sven Schneider, Joost de Kinderen, et al.
American Journal of Rhinology & Allergy|July 15, 2022
Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial DesignLucia De Prado Gomez PharmD MSc, Asif H Khan Mbbs Mph, Anju T Peters Md, et al.
Allergy|January 20, 2023
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposisPhilippe Gevaert, Jarno De Craemer, Claus Bachert, et al.
Frontiers in Allergy|October 29, 2025
Real-life evaluation of the effectiveness of biologics for chronic rhinosinusitis with nasal polyps in Europe: a Delphi study to define key variables for the INVENT registryVibeke Backer, Eugenio De Corso, Geoffrey Mortuaire, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|December 29, 2023
Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal PolypsClaire Hopkins, Joaquim Mullol, Asif H Khan, et al.
Journal of Asthma and Allergy|April 5, 2023
Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 TrialJorge F Maspero, Asif H Khan, Carl Philpott, et al.
Allergologie Select|June 3, 2021
Precision medicine reaching out to the patients in allergology - a German-Japanese workshop reportOliver Pfaar, Katharina Blumchen, Eistine Boateng, et al.
The Journal of Allergy and Clinical Immunology|February 24, 2023
Nasal allergen challenge (NAC): Practical aspects and applications from an EU/US perspective-a Work Group Report of the AAAAI Rhinitis, Rhinosinusitis and Ocular Allergy CommitteeSeong H Cho, Anil Nanda, Anjeni Keswani, et al.
Eclinicalmedicine|January 27, 2025
Roads to remission: evolving treatment concepts in type 2 inflammatory diseasesMarek Lommatzsch, Katharina Blumchen, Lisa A Beck, et al.
The Lancet. Respiratory Medicine|October 1, 2025
Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trialEugenio De Corso, G Walter Canonica, Enrico Heffler, et al.
The Journal of Allergy and Clinical Immunology|November 1, 2024
Real-world effectiveness of dupilumab in a European cohort of chronic rhinosinusitis with nasal polyps (CHRINOSOR)Sven F Seys, Sven Schneider, Joost de Kinderen, et al.
American Journal of Rhinology & Allergy|July 15, 2022
Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial DesignLucia De Prado Gomez PharmD MSc, Asif H Khan Mbbs Mph, Anju T Peters Md, et al.
Allergy|January 20, 2023
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposisPhilippe Gevaert, Jarno De Craemer, Claus Bachert, et al.
Frontiers in Allergy|October 29, 2025
Real-life evaluation of the effectiveness of biologics for chronic rhinosinusitis with nasal polyps in Europe: a Delphi study to define key variables for the INVENT registryVibeke Backer, Eugenio De Corso, Geoffrey Mortuaire, et al.
Pageof 9